focus -WSS

focus

author：comprehensive 2025-08-12 08:27:13 - browse：87765

Erik Tokat -- biotech JPM coverage from STAT — Eric Tokat is co-president of investment banking at Centerview Partners. Courtesy Centerview Partners

SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years.

That’s not idle speculation. It’s perhaps as close to a guarantee one can get in biotech. Last year, Tokat’s advisory firm, Centerview Partners, was involved in 19 of the 23 biotech transactions valued at $1 billion or more. Two more acquisitions of Centerview clients — Harpoon Therapeutics and Ambrx Biopharma — were announced Monday morning.

“I’m not sure if we’re going to have 23 deals or 25 deals, but I think it’s going to be a good year,” said Tokat, speaking to STAT over coffee on the sidelines of the J.P. Morgan Healthcare Conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Medicare drug price negotiation continues, as pharma counteroffers

entertainment

WSS

Families look for replacement for GSK asthma drug Flovent

When is a doctor not a doctor? Try when patients address women doctors

A new study asks: Are we harming blood donors by taking blood?

Grail is spending more than ever lobbying Congress

Change Healthcare: What is it, why does its cyberattack matter?

Connecting traumatic brain injury and domestic violence

explore

focus

hotspot

Cancer drug shortages should be causing more outrage

The public health thinking behind the CDC’s new Covid guidance

Moonlake's readout produced a cash windfall. Risks remain

Fetal cell organoids grown from amniotic fluid, study finds

Jerome Adams on the need for new antivirals for Covid

PhRMA sues HHS over Medicare drug price negotiation

Continuity nursing helped my family in our darkest PICU moments

RaDonda Vaught case: a double standard for nurses, physicians

Hollywood unions extend contract negotiations for actors

Fetal cell organoids grown from amniotic fluid, study finds

Wikipedia

Australia's humpback populations rebound raising hopes of marine scientists

Did the public have the right to know Arthur Ashe had AIDS?

Listen: Biogen's messy board & Laronde's data problem

Microsoft's Peter Lee: Generative AI could help doctors be more human

Can food be medicine? And other questions about a new push

Fetal cell organoids grown from amniotic fluid, study finds

explore

focus

entertainment

focus